Bioventus Inc.
BVSNASDAQHealthcare● Active
$8.95
$-0.09(-1.00%)
Market Cap$606345030
P/E Ratio—
52W High$11.249
52W Low$5.81
Bioventus Inc.（BVS）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BVS · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.05B | $0.04B | $0.04B | $0.03B | $0.04B |
| Net Receivables | $0.13B | $0.13B | $0.12B | $0.14B | $0.12B |
| Inventory | $0.08B | $0.09B | $0.09B | $0.08B | $0.06B |
| Total Current Assets | $0.27B | $0.28B | $0.27B | $0.27B | $0.26B |
| PP&E Net | $0.03B | $0.03B | $0.05B | $0.04B | $0.04B |
| Goodwill | $0.01B | $0.01B | $0.01B | $0.01B | $0.15B |
| Intangible Assets | $0.37B | $0.40B | $0.48B | $0.64B | $0.70B |
| Total Assets | $0.68B | $0.73B | $0.81B | $1.37B | $1.23B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.03B | $0.03B | $0.03B | $0.02B |
| Accounts Payable | $0.01B | $0.02B | $0.02B | $0.04B | $0.02B |
| Total Current Liabilities | $0.16B | $0.21B | $0.18B | $0.30B | $0.18B |
| Long-Term Debt | $0.28B | $0.31B | $0.37B | $0.39B | $0.34B |
| Total Liabilities | $0.46B | $0.54B | $0.59B | $0.96B | $0.69B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.33B) | ($0.36B) | ($0.32B) | ($0.17B) | ($0.01B) |
| Total Stockholders Equity | $0.18B | $0.15B | $0.17B | $0.33B | $0.46B |
| Total Liab & Equity(computed) | $0.64B | $0.69B | $0.76B | $1.29B | $1.15B |
| Debt Summary | |||||
| Total Debt | $0.31B | $0.34B | $0.39B | $0.42B | $0.36B |
| Net Debt | $0.26B | $0.29B | $0.36B | $0.39B | $0.31B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Bioventus Inc.
关于Bioventus Inc.（BVS）资产负债表
Bioventus Inc.总资产$0.68B，现金及短期投资$0.05B，总负债$0.46B，总债务$0.31B，股东权益$0.18B。
常见问题
BVS · 4 问Bioventus Inc.总债务$0.31B，净债务$0.26B。
BVS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10